Minimum 20 minute delay
11/28/2014 9:51:00 AMMINNEAPOLIS AND DUBLIN, Ireland – Nov. 28, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the European Commission has conditionally cleared Medtronic’s proposed acquisition of Covidien. The clearance decision is conditional on Medtronic’s commitment to divest Covidien’s drug coated balloon business. As previously announced, a subsidiary of Covidien entered into an agreement to divest Covidien’s drug coated balloon business to The Spectranetics Corporation, and the divestiture is expected to close shortly following completion of Medtronic’s acquisition of Covidien.…
11/26/2014 2:04:00 PMMINNEAPOLIS AND DUBLIN, Ireland – Nov. 26, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced th e receipt of U.S. Federal Trade Commission (FTC) clearance of Medtronic’s proposed acquisition of Covidien. “This regulatory clearance represents an important milestone in bringing our companies together,” said Omar Ishrak, Chairman and CEO of Medtronic. “We continue to make good progress in planning for the integration of these two companies which will unite them under a single mission – to alleviate pain, restore health and extend life for patients with chronic disease around the world. When the transaction …
11/24/2014 4:05:27 PMFortrex™ PTA Balloon Facilitates Arteriovenous Access in Patients Receiving Hemodialysis for Chronic Kidney Disease DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 24, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for its Fortrex™ over-the-wire (OTW) percutaneous transluminal angioplasty (PTA) balloon catheter. The Fortrex™ 0.035” OTW PTA balloon catheter —the next-generation high pressure solution to maintain arteriovenous (AV) access—is also intended for use in the peripheral vascular system. A common procedure is to …
Covidien in the News
World Stroke Day
Covidien has joined with the World Stroke Organization and other organizations around the globe to recognize World Stroke Day on October 29. Through our Take 2…Tell 2 campaign, we are helping raise awareness about the signs and symptoms of stroke and what to do if they occur. We’re encouraging everyone to take two minutes to learn about the signs and symptoms of stroke, to share that knowledge with two other people and then tell their stroke story through social media using the hashtag #Take2forStroke.
A Partner in Health
Collaborating with physicians and other healthcare professionals, focusing on research and development and maintaining clinical leadership add up to innovative medical solutions that make a difference.
Ensuring ethical interactions with healthcare professionals is vital to the global healthcare environment. Covidien’s Conscientious Collaboration platform is our commitment to open communications about the need to ensure compliant interactions with our customers and partners.